Health

Wegovy maker Novo Nordisk ended its partnership with Hims & Hers, citing allegations about Hims’ compounding and deceptive marketing practices. Hims & Hers shares dropped more than 30%

June 23, 2025
Sandra J Burns

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims’ compounding and deceptive marketing practices.

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading